A new report released by the BioIndustry Association (BIA) and Informa Pharma Intelligence has revealed that the UK has the strongest research and development (R&D) pipeline in Europe.
The Access to Medicine Foundation has published an independent analysis of the efforts made by pharma companies to address the issue of drug resistant infections.
In this online exclusive, Jessica Foreman, freelance writer who works within the life sciences sector, reveals her guide on how to ensure you are maximising value at each stage of product development
A new joint report from the Medicines Discovery Catapult and the UK BioIndustry Association (BIA), released today (Thursday 18 January) has revealed insights into the productivity of the UK’s drug discovery community.
A study of clinical trial professionals has revealed the top challenges and frustrations with current Randomization and Trial Supply Management/Interactive Response Technology (RTSM/IRT) systems as well as opportunities for improvement.
A recent report from CPhI Japan has forecast that this year, 2018, will be a transformative year for Japanese pharma as the market is expected to see growth in generics, biosimilars and internationalisation.
SCORR Marketing, health science marketing and communications firm, has released a new survey report evaluating how satisfied employees of the clinical research industry are and whether salary is an indicator of job satisfaction.
A recently published survey has demonstrated an optimistic outlook of a growing global economy that will sustain new orders and industry growth by British manufacturers.
Jean-Marie Aulnette, vice president of EMEA Sales, TraceLink, reveals his thoughts on the challenges, opportunities and trends experienced over the course of the past 12 months.
As we get set for Pharmapack Europe, taking place early next year — 7 & 8 February, we preview some of the key aspects of this event that makes it an inevitable industry favourite.
Here, Maria Yasko, PR manager at phamax, lists five countries with limited access to healthcare, going into detail about how these countries are suffering from healthcare sector problems and how these are getting in the way of patient access.
